Breadcrumb
Wound Dressings Market - Global Forecast to 2021
Publisher: MarketsandMarkets
Published: 2016/06/22
Page: 186
Format: PDF
Price:
USD 5,650 (Single-User License)
USD 6,650 (Multi-User License)
USD 10,000 (Global-User License)
USD 6,650 (Multi-User License)
USD 10,000 (Global-User License)
The global wound dressings market is expected to reach USD 8.46 billion by 2021 from USD 6.31 billion in 2015, at a CAGR of 6.0% from 2016 to 2021. The advanced wound dressings segment is expected to contribute 77.2% share to the overall market in 2016. Introduction of new and advanced wound dressing products is fueling the growth of wound dressings market.
“Foam dressings to contribute largest share in wound dressings market”
In advanced wound dressings, the foam dressings segment is estimated to be valued highest in 2016, and is projected to continue holding largest share throughout the forecast period. Europe is the major market for this segment. The high share of foam dressings segment is attributed to increasing patient awareness regarding advanced wound products, increasing incidences of diabetes, and increase in aged population.
Companies operating in the advanced wound care market have received FDA approvals to increase their product offerings in this market. Key players operating in this market include Smith & Nephew plc (U.K.), 3M Company (U.S.), ConvaTec Inc. (U.S.), Hollister Wound Care (U.S.), Molnlycke Health Care AB (Sweden), and BSN Medical (Germany).
“Alginate dressings is the fastest-growing segment of wound dressings market”
Alginate dressings are biodegradable, reduce pain, and keep the tissues moist during healing. Alginate dressings help in the absorption of wound exudates and form a gel-like covering over the wound, which further aids in retention of moisture. The alginate has the capacity to absorb 20 times its weight in exudates and facilitates the process of autolytic debridement. These advantages of alginates over other dressings are expected to drive the growth of alginates segment at the highest CAGR during the forecast period.
Alginate dressings are best suited for pressure and diabetic foot ulcers and venous leg ulcers, post-operative wounds, cavity wounds, traumatic wounds, malignant wounds, pilonidal sinus wounds, partial thickness burns, graft donor sites, and abrasions. They are also used to control minor bleeding. New products in alignates segment are being developed by several companies. Key players in the alignates market include Smith & Nephew plc (U.K.), 3M Company (U.S.), Hollister, Inc. (U.S.), and Molnlycke Health Care AB (Sweden).
Reasons to buy this report:
From an insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends), market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the wound dressings market; high-growth regions; and market drivers, restraints, and opportunities.
The report provides insights on the following pointers:
‧ Market Penetration: Comprehensive information on wound dressings offered by the top players in the global wound dressings market
‧ Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the wound dressings market
‧ Market Development: Comprehensive information about lucrative emerging markets – the report analyzes the markets for wound dressings across regions
‧ Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global wound dressings market
Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global wound dressings market
“Foam dressings to contribute largest share in wound dressings market”
In advanced wound dressings, the foam dressings segment is estimated to be valued highest in 2016, and is projected to continue holding largest share throughout the forecast period. Europe is the major market for this segment. The high share of foam dressings segment is attributed to increasing patient awareness regarding advanced wound products, increasing incidences of diabetes, and increase in aged population.
Companies operating in the advanced wound care market have received FDA approvals to increase their product offerings in this market. Key players operating in this market include Smith & Nephew plc (U.K.), 3M Company (U.S.), ConvaTec Inc. (U.S.), Hollister Wound Care (U.S.), Molnlycke Health Care AB (Sweden), and BSN Medical (Germany).
“Alginate dressings is the fastest-growing segment of wound dressings market”
Alginate dressings are biodegradable, reduce pain, and keep the tissues moist during healing. Alginate dressings help in the absorption of wound exudates and form a gel-like covering over the wound, which further aids in retention of moisture. The alginate has the capacity to absorb 20 times its weight in exudates and facilitates the process of autolytic debridement. These advantages of alginates over other dressings are expected to drive the growth of alginates segment at the highest CAGR during the forecast period.
Alginate dressings are best suited for pressure and diabetic foot ulcers and venous leg ulcers, post-operative wounds, cavity wounds, traumatic wounds, malignant wounds, pilonidal sinus wounds, partial thickness burns, graft donor sites, and abrasions. They are also used to control minor bleeding. New products in alignates segment are being developed by several companies. Key players in the alignates market include Smith & Nephew plc (U.K.), 3M Company (U.S.), Hollister, Inc. (U.S.), and Molnlycke Health Care AB (Sweden).
Reasons to buy this report:
From an insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends), market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the wound dressings market; high-growth regions; and market drivers, restraints, and opportunities.
The report provides insights on the following pointers:
‧ Market Penetration: Comprehensive information on wound dressings offered by the top players in the global wound dressings market
‧ Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the wound dressings market
‧ Market Development: Comprehensive information about lucrative emerging markets – the report analyzes the markets for wound dressings across regions
‧ Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global wound dressings market
Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global wound dressings market
TABLE OF CONTENTS
1 INTRODUCTION 18
1.1 OBJECTIVES OF THE STUDY 18
1.2 MARKET DEFINITION 18
1.3 MARKET SCOPE 18
1.3.1 MARKETS COVERED 18
1.3.2 YEARS CONSIDERED FOR THE STUDY 19
1.4 CURRENCY & PRICING 19
1.5 STAKEHOLDERS 19
2 RESEARCH METHODOLOGY 20
2.1 MARKET SIZE ESTIMATION 21
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 24
2.3 MARKET SHARE ESTIMATION 25
2.3.1 KEY DATA FROM SECONDARY SOURCES 25
2.3.2 KEY DATA FROM PRIMARY SOURCES 26
2.3.3 ASSUMPTIONS FOR THE STUDY 26
2.4 INTEGRATED ECOSYSTEM OF ADVANCED WOUND DRESSINGS MARKET 27
3 EXECUTIVE SUMMARY 28
4 PREMIUM INSIGHTS 34
4.1 LUCRATIVE OPPORTUNITIES IN THE WOUND DRESSINGS MARKET 34
5 MARKET OVERVIEW 36
5.1 INTRODUCTION 36
5.2 MARKET SEGMENTATION 36
5.2.1 BY TYPE 36
5.2.2 WOUND DRESSINGS MARKET, BY APPLICATION 37
5.2.3 WOUND DRESSINGS MARKET, BY END USER 37
5.3 MARKET DYNAMICS 38
5.3.1 DRIVERS 39
5.3.1.1 Rise in aging population 39
5.3.1.2 Rising incidences of diabetes 40
5.3.1.3 Technological advancements 40
5.3.1.4 Government initiatives 41
5.3.1.5 Rising awareness of new technologies 41
5.3.2 MARKET RESTRAINTS 41
5.3.2.1 High cost of technologically-advanced products 41
5.3.3 MARKET OPPORTUNITIES 41
5.3.3.1 High growth potential for the growth of the market in Asia 41
5.3.3.2 Acquisitions by leading companies in the market 42
5.3.4 MARKET CHALLENGES 42
5.3.4.1 Competitive pricing pressure 42
6 GLOBAL WOUND DRESSINGS MARKET, BY TYPE 43
6.1 INTRODUCTION 44
6.2 ADVANCED WOUND DRESSINGS 45
6.2.1 ADVANCED WOUND DRESSINGS MARKET, BY PRODUCT 47
6.2.1.1 Foam Dressings 48
6.2.1.2 Hydrocolloids 49
6.2.1.3 Hydrofiber 50
6.2.1.4 Film Dressings 52
6.2.1.5 Alginates 53
6.2.1.6 COLLAGEN DRESSINGS 54
6.2.1.7 Hydrogels Dressings 56
6.2.1.8 Wound Contact Layers 57
6.2.1.9 SUPERABSORBENT DRESSINGS 59
6.3 TRADITIONAL WOUND DRESSINGS 60
6.3.1 TRADITIONAL WOUND DRESSINGS MARKET, BY TYPE 61
6.3.1.1 Surgical Tapes 62
6.3.1.2 Anti-Infective Dressings 63
6.3.1.3 Dry Dressings 65
7 GLOBAL WOUND DRESSINGS MARKET, BY APPLICATION 67
7.1 INTRODUCTION 68
7.2 SURGICAL WOUNDS 69
7.2.1 TRAUMA WOUNDS 70
7.3 BURNS 71
7.4 DIABETIC FOOT ULCERS 72
7.5 PRESSURE ULCERS 74
7.6 VENOUS ULCERS 75
8 GLOBAL WOUND DRESSINGS MARKET, BY END USER 77
8.1 INTRODUCTION 78
8.2 INPATIENT FACILITIES 79
8.3 OUTPATIENT FACILITIES 80
9 GLOBAL WOUND DRESSINGS MARKET, BY REGION 81
9.1 INTRODUCTION 82
9.2 NORTH AMERICA 82
9.2.1 U.S. 90
9.2.1.1 Rising incidences of acute and chronic wounds will propel market growth 90
9.2.1.2 Changes in reimbursement policies will drive the growth of cost-effective wound care products 91
9.2.1.3 Government support will trigger market growth 91
9.2.2 CANADA 93
9.2.2.1 Venture capitalist investments to drive the growth of the market 93
9.2.2.2 Increasing awareness regarding wound care and collaboration among companies manufacturing wound dressings are influencing the growth of this market 93
9.2.3 MEXICO 95
9.3 EUROPE 97
9.3.1 GERMANY 105
9.3.1.1 Collaboration among players involved in the manufacture of wound dressings facilitates product innovation 105
9.3.2 FRANCE 107
9.3.2.1 Investments made by prominent players in the wound dressings market is expected to drive its growth 107
9.3.3 U.K. 110
9.3.3.1 Entry of foreign companies in the U.K. to propel market growth 110
9.3.3.2 Government support, an impetus for the market 110
9.3.4 ITALY 112
9.3.4.1 Collaboration among major players operating in the wound dressings market propels market growth 112
9.3.5 SPAIN 115
9.3.5.1 Conferences and seminars to create awareness regarding innovative wound care products 115
9.4 ASIA 117
9.4.1.1 Rise in diabetic population and chronic wounds to propel growth in the Asian wound dressings market 117
9.4.1.2 Investments made by prominent companies in the Asian wound dressings market to offer lucrative growth opportunities 117
9.4.1.3 Research activities to propel market growth 118
9.4.1.4 Lack of reimbursement in some of the Asian countries may restraint the growth of the wound dressings market 118
9.4.2 JAPAN 126
9.4.3 CHINA 128
9.4.4 INDIA 130
9.4.5 REPUBLIC OF KOREA 132
9.5 REST OF THE WORLD (ROW) 134
9.5.1 GROWING AGING AND DIABETIC POPULATION TO DRIVE THE MARKET GROWTH 134
9.5.2 LAUNCH OF INNOVATIVE WOUND DRESSINGS TO TRIGGER MARKET GROWTH 134
9.5.3 RISE IN THE NUMBER OF RESEARCH-RELATED ACTIVITIES TO PROPEL THE GROWTH OF THE WOUND DRESSINGS MARKET 134
10 COMPETITIVE LANDSCAPE 141
10.1 COMPANY SHARE ANALYSIS 141
10.2 NEW PRODUCT LAUNCHES 142
10.3 PARTNERSHIPS 143
10.4 MERGERS & ACQUISITIONS 144
10.5 AGREEMENTS 145
10.6 REGULATORY APPROVALS 146
10.7 EXPANSIONS 146
10.8 ANNOUNCEMENTS 147
11 COMPANY PROFILES 148
(Company at a Glance, Recent Financials, Products & Services, Strategies & Insights, & Recent Developments)*
11.1 ACELITY L.P., INC. 148
11.2 SMITH AND NEPHEW PLC 151
11.3 INTEGRA LIFESCIENCES HOLDINGS CORP. 154
11.4 MOLNLYCKE HEALTH CARE 157
11.5 CONVATEC, INC. 159
11.6 COLOPLAST CORP. 162
11.7 ORGANOGENESIS INC. 165
11.8 MEDLINE INDUSTRIES, INC. 166
11.9 3M COMPANY 168
11.10 COVIDIEN PLC 172
11.11 DERMA SCIENCES, INC. 175
11.12 HOLLISTER, INC. 178
*Details on company at a glance, recent financials, products & services, strategies & insights, & recent developments might not be captured in case of unlisted companies.
12 APPENDIX 179
12.1 INSIGHTS FROM INDUSTRY EXPERTS 179
12.2 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 180
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 181
12.4 AVAILABLE CUSTOMIZATIONS 183
12.5 RELATED REPORTS 183
12.6 RT SNAPSHOT 184
1 INTRODUCTION 18
1.1 OBJECTIVES OF THE STUDY 18
1.2 MARKET DEFINITION 18
1.3 MARKET SCOPE 18
1.3.1 MARKETS COVERED 18
1.3.2 YEARS CONSIDERED FOR THE STUDY 19
1.4 CURRENCY & PRICING 19
1.5 STAKEHOLDERS 19
2 RESEARCH METHODOLOGY 20
2.1 MARKET SIZE ESTIMATION 21
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 24
2.3 MARKET SHARE ESTIMATION 25
2.3.1 KEY DATA FROM SECONDARY SOURCES 25
2.3.2 KEY DATA FROM PRIMARY SOURCES 26
2.3.3 ASSUMPTIONS FOR THE STUDY 26
2.4 INTEGRATED ECOSYSTEM OF ADVANCED WOUND DRESSINGS MARKET 27
3 EXECUTIVE SUMMARY 28
4 PREMIUM INSIGHTS 34
4.1 LUCRATIVE OPPORTUNITIES IN THE WOUND DRESSINGS MARKET 34
5 MARKET OVERVIEW 36
5.1 INTRODUCTION 36
5.2 MARKET SEGMENTATION 36
5.2.1 BY TYPE 36
5.2.2 WOUND DRESSINGS MARKET, BY APPLICATION 37
5.2.3 WOUND DRESSINGS MARKET, BY END USER 37
5.3 MARKET DYNAMICS 38
5.3.1 DRIVERS 39
5.3.1.1 Rise in aging population 39
5.3.1.2 Rising incidences of diabetes 40
5.3.1.3 Technological advancements 40
5.3.1.4 Government initiatives 41
5.3.1.5 Rising awareness of new technologies 41
5.3.2 MARKET RESTRAINTS 41
5.3.2.1 High cost of technologically-advanced products 41
5.3.3 MARKET OPPORTUNITIES 41
5.3.3.1 High growth potential for the growth of the market in Asia 41
5.3.3.2 Acquisitions by leading companies in the market 42
5.3.4 MARKET CHALLENGES 42
5.3.4.1 Competitive pricing pressure 42
6 GLOBAL WOUND DRESSINGS MARKET, BY TYPE 43
6.1 INTRODUCTION 44
6.2 ADVANCED WOUND DRESSINGS 45
6.2.1 ADVANCED WOUND DRESSINGS MARKET, BY PRODUCT 47
6.2.1.1 Foam Dressings 48
6.2.1.2 Hydrocolloids 49
6.2.1.3 Hydrofiber 50
6.2.1.4 Film Dressings 52
6.2.1.5 Alginates 53
6.2.1.6 COLLAGEN DRESSINGS 54
6.2.1.7 Hydrogels Dressings 56
6.2.1.8 Wound Contact Layers 57
6.2.1.9 SUPERABSORBENT DRESSINGS 59
6.3 TRADITIONAL WOUND DRESSINGS 60
6.3.1 TRADITIONAL WOUND DRESSINGS MARKET, BY TYPE 61
6.3.1.1 Surgical Tapes 62
6.3.1.2 Anti-Infective Dressings 63
6.3.1.3 Dry Dressings 65
7 GLOBAL WOUND DRESSINGS MARKET, BY APPLICATION 67
7.1 INTRODUCTION 68
7.2 SURGICAL WOUNDS 69
7.2.1 TRAUMA WOUNDS 70
7.3 BURNS 71
7.4 DIABETIC FOOT ULCERS 72
7.5 PRESSURE ULCERS 74
7.6 VENOUS ULCERS 75
8 GLOBAL WOUND DRESSINGS MARKET, BY END USER 77
8.1 INTRODUCTION 78
8.2 INPATIENT FACILITIES 79
8.3 OUTPATIENT FACILITIES 80
9 GLOBAL WOUND DRESSINGS MARKET, BY REGION 81
9.1 INTRODUCTION 82
9.2 NORTH AMERICA 82
9.2.1 U.S. 90
9.2.1.1 Rising incidences of acute and chronic wounds will propel market growth 90
9.2.1.2 Changes in reimbursement policies will drive the growth of cost-effective wound care products 91
9.2.1.3 Government support will trigger market growth 91
9.2.2 CANADA 93
9.2.2.1 Venture capitalist investments to drive the growth of the market 93
9.2.2.2 Increasing awareness regarding wound care and collaboration among companies manufacturing wound dressings are influencing the growth of this market 93
9.2.3 MEXICO 95
9.3 EUROPE 97
9.3.1 GERMANY 105
9.3.1.1 Collaboration among players involved in the manufacture of wound dressings facilitates product innovation 105
9.3.2 FRANCE 107
9.3.2.1 Investments made by prominent players in the wound dressings market is expected to drive its growth 107
9.3.3 U.K. 110
9.3.3.1 Entry of foreign companies in the U.K. to propel market growth 110
9.3.3.2 Government support, an impetus for the market 110
9.3.4 ITALY 112
9.3.4.1 Collaboration among major players operating in the wound dressings market propels market growth 112
9.3.5 SPAIN 115
9.3.5.1 Conferences and seminars to create awareness regarding innovative wound care products 115
9.4 ASIA 117
9.4.1.1 Rise in diabetic population and chronic wounds to propel growth in the Asian wound dressings market 117
9.4.1.2 Investments made by prominent companies in the Asian wound dressings market to offer lucrative growth opportunities 117
9.4.1.3 Research activities to propel market growth 118
9.4.1.4 Lack of reimbursement in some of the Asian countries may restraint the growth of the wound dressings market 118
9.4.2 JAPAN 126
9.4.3 CHINA 128
9.4.4 INDIA 130
9.4.5 REPUBLIC OF KOREA 132
9.5 REST OF THE WORLD (ROW) 134
9.5.1 GROWING AGING AND DIABETIC POPULATION TO DRIVE THE MARKET GROWTH 134
9.5.2 LAUNCH OF INNOVATIVE WOUND DRESSINGS TO TRIGGER MARKET GROWTH 134
9.5.3 RISE IN THE NUMBER OF RESEARCH-RELATED ACTIVITIES TO PROPEL THE GROWTH OF THE WOUND DRESSINGS MARKET 134
10 COMPETITIVE LANDSCAPE 141
10.1 COMPANY SHARE ANALYSIS 141
10.2 NEW PRODUCT LAUNCHES 142
10.3 PARTNERSHIPS 143
10.4 MERGERS & ACQUISITIONS 144
10.5 AGREEMENTS 145
10.6 REGULATORY APPROVALS 146
10.7 EXPANSIONS 146
10.8 ANNOUNCEMENTS 147
11 COMPANY PROFILES 148
(Company at a Glance, Recent Financials, Products & Services, Strategies & Insights, & Recent Developments)*
11.1 ACELITY L.P., INC. 148
11.2 SMITH AND NEPHEW PLC 151
11.3 INTEGRA LIFESCIENCES HOLDINGS CORP. 154
11.4 MOLNLYCKE HEALTH CARE 157
11.5 CONVATEC, INC. 159
11.6 COLOPLAST CORP. 162
11.7 ORGANOGENESIS INC. 165
11.8 MEDLINE INDUSTRIES, INC. 166
11.9 3M COMPANY 168
11.10 COVIDIEN PLC 172
11.11 DERMA SCIENCES, INC. 175
11.12 HOLLISTER, INC. 178
*Details on company at a glance, recent financials, products & services, strategies & insights, & recent developments might not be captured in case of unlisted companies.
12 APPENDIX 179
12.1 INSIGHTS FROM INDUSTRY EXPERTS 179
12.2 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 180
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 181
12.4 AVAILABLE CUSTOMIZATIONS 183
12.5 RELATED REPORTS 183
12.6 RT SNAPSHOT 184
